Funding will drive expansion of company’s product portfolio and commercial reach. SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has closed a total of $50 million in financing from a Series C equity raise and the closing of a debt facility. Soleus Capital led the Series […]

Technology, in-licensed from the Massachusetts Institute of Technology (MIT), capable of inserting DNA sequences of any size into any programmed genomic location Potential to create curative cell and integrative gene therapies Backed by leading biotech investors Andreessen Horowitz, ARCH, GV, Longwood, Polaris and others Watertown, MA – Tome Biosciences, Inc., the programmable genomic integration company, has […]

Doug Doerfler, President and CEO, to Retire Effective December 31, 2023; will continue to serve as an advisor to MaxCyte Maher Masoud, EVP, Head of Global Business Development and Chief Counsel, to Succeed Mr. Doerfler as President and CEO, Effective January 1, 2024 MaxCyte is reiterating 2023 expected core business revenue of $28-30 million, and the Company now expects to […]

WOBURN, Mass. — Spear Bio Inc., a Harvard University biotech spin-off developing scalable solutions for ultrasensitive detection of protein biomarkers, announced the completion of a raise of tens of millions of US dollars with its Seed Prime. The oversubscribed round was led by CDH Investments, with additional investments from earlier investors such as Maverick Ventures and YongHua […]

LONDON, November 30, 2023—Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ Capital and Wing VC. The funding will accelerate the manufacturing and distribution of Mytos’ automated cell production system to more biotech and pharma companies to meet […]

ThinkCyte today announced the successful completion of a funding round, raising $24 million USD (approx. JPY 3.3 billion). TOKYO, JAPAN — ThinkCyte today announced the successful completion of a funding round, raising $24 million USD (approx. JPY 3.3 billion) from both equity investments and a non-dilutive grant. Leading the investment were Nomura SPARX Investment, with participation […]

Gümligen, Bern — Spacetek Technology AG, a trailblazing company specializing in the design and production of time-of-flight mass spectrometers (TOF-MS) inspired by space technology, has successfully completed its seed financing round in October 2023. Led by Swisscom Ventures, 5.8 million CHF in funding has been secured from a group of financial investors. The Spectrum Moonshot […]

The Eindhoven-based deep-tech company MantiSpectra, a Spinoff of the Eindhoven University of Technology, has successfully secured €4 million funding to support its mission to revolutionize how we ‘see’ the world around us by enabling the adoption of near-infrared spectroscopy everywhere. Innovation Industries and PhotonVentures led the funding round. Together with the support from the PhotonDelta National Growth Fund programme, this […]

VANCOUVER, B.C. and PRINCETON, NJ — Xybion Digital Inc. (TSXV: XYBN) (“Xybion” or the “Company“) is pleased to announce the closing of an acquisition (the “Acquisition”) of all of the issued and outstanding shares in the capital of Autoscribe Limited (“Autoscribe”) pursuant to a share purchase agreement among the Company, Autoscribe and all of the […]

BAGNEUX, France, Genomic Vision (FR0011799907 – GV, the “Company”), a Euronext-listed biotechnology company that develops products and services for the highly accurate characterization of transformed cells, announces having filed today a declaration of cessation of payments (“déclaration de cessation des paiements”) with the Commercial Court of Nanterre. The employee representative bodies were informed on October […]